Moteur de recherche d’entreprises européennes
Financement de l’UE (4 009 373 €) : Réseau de formation sur les vaccins innovants antibactériens. Hor28/08/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Réseau de formation sur les vaccins innovants antibactériens.
BactiVax (anti-Bacterial Innovative Vaccine Training Network) is a European training network (ETN) that will provide high-level training in vaccinology to a new generation of 15 high-achieving, early-stage researchers (ESRs). This innovative ETN uniquely blends cutting-edge research training, non-academic placements and transferable skills. It will develop strong entrepreneurial and creative mindsets. BactiVax will train ESRs in a broad range of transferable skills enabling them to thrive in careers in vaccine research within academia and/or industry through discovery, development, and delivery of innovative therapeutic and prophylactic vaccines. The World Health Organisation has identified antimicrobial resistance (AMR) as one of the three greatest threats to mankind. There is a urgent need to train innovative ESRs in the development of new vaccines against AMR infections. BactiVax will tackle the societal challenge caused by the emergence of AMR pathogens and have significant impact on pathogens causing chronic, life-threatening respiratory and/or systemic infections. BactiVax training will cover critical areas of vaccinology from early antigen discovery to optimisation of host response and delivery of vaccine antigens. It will also encompass the increasing problem of vaccine hesitancy in its public engagement. The specific research objectives are to: 1) Identify novel, protective vaccine antigens against target pathogens; 2) Optimise the host response to vaccines; 3) Optimise vaccine delivery; 4) Lead on vaccine advocacy. BactiVax includes 2 SME beneficiaries, a multinational vaccine company and 4 SMEs as partners all of whom are involved in training, entrepreneurship, commercial vaccine development and vaccine antigen processing. All ESRs will have secondments in non-academic environment to enhance their exposure to the commercial. Overall, BactiVax will provide ESRs with rich experience and advanced multidisciplinary skills in the cutting edge area of vaccines
| Asociacion Centro de Investigacion CRL en Biociencias | 501 810 € |
| Consiglio Nazionale Delle Ricerche | 261 500 € |
| ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE | 281 277 € |
| EOTVOS LORAND TUDOMANYEGYETEM | 229 715 € |
| Immunxperts | 256 320 € |
| Imperial College of Science Technology and Medicine | 303 173 € |
| LIONEX GmbH | 252 788 € |
| LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN | 505 577 € |
| St George's Hospital Medical School | 303 173 € |
| The Queen's University of Belfast | 303 173 € |
| Universita' Degli Studi Di Milano-Bicocca | 261 500 € |
| University College Dublin, National University of Ireland, Dublin | 549 369 € |
https://cordis.europa.eu/project/id/860325
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
